VRC Clinical Monitoring Initiative 2017-2024

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, established this Master IDIQ on July 31, 2017 to procure clinical monitoring and trial support services for the Vaccine Research Center (VRC). Ordering closed on July 31, 2024, making this vehicle inactive for new task orders.

The vehicle is no longer available for pursuing. The ordering period ended nearly two years ago, and no task orders have been awarded since July 28, 2023. The master agreement itself has expired.

Work contracted under the vehicle focuses on clinical monitoring coordination and trial-support activities across VRC vaccine and therapeutic research protocols spanning infectious diseases including HIV, malaria, influenza, Ebola, and Marburg virus. Task orders price on a cost-plus-fixed-fee basis with typical ceiling values ranging from $16,500 to $332,500 and performance periods of one to three years.

Technical Resources International, Inc. dominates the vehicle, holding ten of 19 task orders worth $1.3 million combined potential value (65 percent of total). The Emmes Company, LLC captured seven orders for $725 thousand (36 percent), while Navitas Clinical Research Inc. received two orders for $17 thousand. Nearly all work—95 percent of orders—was awarded unrestricted; a single $48,200 small-business order went to an unspecified 8(a) contractor in 2018.

The National Institute of Allergy and Infectious Diseases funded 18 of 19 task orders, representing $2 million of the combined potential value. One order ($48,000) funded the National Institute of Diabetes and Digestive and Kidney Diseases.

The vehicle's combined potential value totaled $2 million, with $1.8 million obligated (90 percent). Ordering momentum declined sharply after 2019, dropping from four orders in 2019 to one order each in 2022 and 2023. The most recent order, awarded to an unspecified contractor on July 28, 2023 for influenza clinical trials, obligated $152,341 and extends through May 1, 2026.

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Vaccine Research Center (VRC) has a requirement for General Clinical Research Support Services. The Contractor will coordinate clinical monitoring activities and complete all necessary clinical trial activities to support the VRC's clinical research efforts and enable the VRC to rapidly establish collaborations with academic institutions and health research organizations in response to the urgent research demands of global importance.